Allergan sells Anda to Teva for $500 million
NEW YORK — Another large deal has been struck between Allergan plc and Teva Pharmaceutical Industries Ltd. The companies on Wednesday announced the sale of Allergan’s Anda Inc. distribution business to Teva for $500 million. That came a day after they reported the close of Teva’s $39 billion acquisition of the Allergan’s legacy Actavis generics
